| Dr Erin Johnson, PHD | |
|
4320 Diplomacy Dr, Anchorage, AK 99508 | |
| (907) 729-6650 | |
| Not Available |
| Full Name | Dr Erin Johnson |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 4320 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720369382 | NPI | - | NPPES |
| MH0212 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSYP685 (Alaska) | Primary |
| 103T00000X | Psychologist | (Alaska) | Secondary |
| Entity Name | Southcentral Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
The Coriell Institute for Medical Research, Cooper University Health Care and Cooper Medical School of Rowan University (CMSRU) are launching the Camden Opioid Research Initiative (CORI), a first-of-its-kind undertaking to investigate the genetic and biological factors that contribute to the development of opioid use disorder (also referred to as opioid dependence or addiction).
Inspire Pharmaceuticals, Inc. announced today financial results for the second quarter ended June 30, 2010, reporting a net loss of $8.8 million or ($0.11) per share, an improvement from the second quarter of 2009 during which the Company incurred a net loss of $9.5 million or ($0.17) per share.
Cancer Research UK's chief executive Harpal Kumar today spoke of a 'golden era' for cancer research as the UK is poised to lead the world in individualising the practice of medicine by understanding which treatments are best suited to an individual patient's particular genetic type of cancer.
A team of LSU Health New Orleans scientists discovered that a component of fish oil not only protects cells critical to vision from potentially lethal initial insults, but also from those that occur in the future.
CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erin Johnson, PHD Po Box 966, Nome, AK 99762-0966 Ph: (907) 443-3344 | Dr Erin Johnson, PHD 4320 Diplomacy Dr, Anchorage, AK 99508 Ph: (907) 729-6650 |
News Archive
The Coriell Institute for Medical Research, Cooper University Health Care and Cooper Medical School of Rowan University (CMSRU) are launching the Camden Opioid Research Initiative (CORI), a first-of-its-kind undertaking to investigate the genetic and biological factors that contribute to the development of opioid use disorder (also referred to as opioid dependence or addiction).
Inspire Pharmaceuticals, Inc. announced today financial results for the second quarter ended June 30, 2010, reporting a net loss of $8.8 million or ($0.11) per share, an improvement from the second quarter of 2009 during which the Company incurred a net loss of $9.5 million or ($0.17) per share.
Cancer Research UK's chief executive Harpal Kumar today spoke of a 'golden era' for cancer research as the UK is poised to lead the world in individualising the practice of medicine by understanding which treatments are best suited to an individual patient's particular genetic type of cancer.
A team of LSU Health New Orleans scientists discovered that a component of fish oil not only protects cells critical to vision from potentially lethal initial insults, but also from those that occur in the future.
CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.
› Verified 5 days ago
James Kyle Timmons, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Potlatch Cir, Anchorage, AK 99503 Phone: 907-947-1862 | |
Raymond Pastorino, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-562-1603 | |
Dr. Sally Schliesmann, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2846 Redwood Pl, Anchorage, AK 99508 Phone: 907-278-1200 Fax: 907-276-3147 | |
Cale Palmer, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3001 C St, Anchorage, AK 99503 Phone: 907-273-4023 | |
Suzette Lewis, PSY. D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1825 Academy Dr, Anchorage, AK 99507 Phone: 907-522-7080 Fax: 907-522-7088 | |
Dennis Gall, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4050 Lake Otis Pkwy Ste 105, Anchorage, AK 99508 Phone: 907-433-9628 | |
Kelley Russell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Muldoon Rd, Anchorage, AK 99504 Phone: 907-257-4700 |